IDF cadets developed a digital bracelet to attach to injured soldiers; VBL Therapeutics develops treatment to fight tumors; Zebra Medical Vision has launched fast, accurate medical image analysis over the web, and much more.
A globally praised prostate cancer treatment was developed in Israel; an ultrasound machine for treating tremors is produced by Israel’s Insightec; Tel Aviv University researchers discovered that a popular food supplement can reverse the effects of a debilitating neurodegenerative disorder, and much more.
Key enzyme discovery in fight against cancer; Israeli biotech Neurim signed marketing agreements for its new treatment for sleep disorders in children with autism and neurogenetic diseases; Israeli surgeons from Save a Child’s Heart saved 14 young, faulty hearts, and much more. By: Michael Ordman ISRAEL’S MEDICAL ACHIEVEMENTS Key enzyme discovery in fight against cancer Israel Technion… Read more »
Israel’s Microbot develops miniature robots for cleaning drainage pipes in the body; treatment by Israel’s Teva for Huntington disease has been approved by the US FDA; Tiberias is hosting the 6th Anglo Israel Cardiovascular Symposium, and much more.
Israel is the first country to earn the United Nations’ World Health Organization’s highest ranking for its IDF field hospital unit; Israel’s BiolineRX has developed a novel treatment that can restore liver function in patients with liver disease and injury, and much more.
Israel’s CollPlant has been awarded the EU CE Mark for VergenixSTR, a soft tissue repair matrix for the treatment of tendinopathy; Hebrew University scientists’ peptide treatment for HIV to make it self-destruct has now been tested on the blood from AIDS patients, and much more.
Researchers at Israel’s Weizmann Institute have discovered a link between the level of oxygen breathed by mice and their ability to adapt to a shift in daylight hours; The state-of-the-art control system installed in the Head and Neck Operating Room at Haifa’s Rambam Medical Center is the first of its kind in the world, and much more.
Israel’s Gordian Surgical received CE clearance for its TroClose1200™, an innovative system for inserting surgical instruments into the abdomen; Israeli scientists have designed new peptides that act as decoys, stopping the bacteria from binding with the receptors, and much more.
Israeli researchers have proved that exercise using Virtual Reality (VR) systems can halve the number of incidents of falls in the elderly; Israeli researchers have used gene therapy to prevent metastasis – the spread of breast cancer to other parts of the body, and much more.
Israeli researchers have used brainwaves of humans under strain to control the release of medicine by tiny robots made from shells made of DNA; Israeli-based NRGene is turning its attention to the human genome in order to help diagnose genetic disorders at an early stage, and much more.
Israeli startup VRPhysio matches virtual reality and physiotherapy to help patients exercise and speed up recovery; Hadasit and Israel’s BioLineRx are to develop a treatment for fatty liver disease, and much more.
Israeli biotech Pambio is developing a treatment that prevents bleeding and subsequent damage from brain hemorrhages; Israeli researchers are studying how to use male prawns in Africa to prevent Schistosomiasis, and much more.
Hebrew University of Jerusalem scientists’ development of TXM peptides can reduce the risk of Alzheimer’s and dementia in diabetics; Israeli startup Biotreat 21 has invented what it calls a miracle cream, claiming it could completely regrow damaged skin, and much more.
Israel’s Oramed hopes to make life better for many of the 400 million people with diabetes; Human trials of unique stem cell therapy from Israeli biotech Cell Cure at Hadassah Medical Center are proceeding well, and much more.
Scientists at Bar-Ilan University have used low-level electricity to increase the rate at which daydreams occur; The SafeCT-29 solution from Israel’s Medic Vision Imaging Solutions produces high-quality medical scan images but reduces radiation doses by up to 80%, and much more.
Israeli biotech Kitov has announced that it will be ready at the end of 2016 to launch its treatment for osteoarthritis pain and hypertension; the UK has approved the funding of patients receiving the pioneering melanoma treatment developed by an Israeli Professor, and much more.
WoundClot is a gauze that absorbs 25 times its own weight of blood and forms a coagulating gel membrane on the open wound; Israeli Professor Yoram Palti invents an electrode treatment for aggressive brain tumors, and much more.
Israel’s Collplant is developing plant-based collagen and formulations intended for use as BioInk for 3D printing of tissues and organs; Israel’s HIL Applied Medical developed a safer, focused proton beam lasers to treat tumors, and much more.
The SightDX Parasight Malaria Detection Platform from Israel’s Sight Diagnostics is to be introduced into India; Israel’s LifeSeal, the no-leak sealant solution for patients who have undergone gastrointestinal (GI) surgery, has received CE approval for use in the European Union, and much more.
An Israeli company has developed the Discovery NM/CT 670 CZT system to perform faster, more accurate, safer and less intrusive SPECT/CT scans of the body; Israeli biotech Oramed has reported success in the Phase IIb study of its insulin capsule, and much more.
Researchers at Israel’s Weizmann Institute have found new RNA-control switches (“ribo-switches) for genes encoding antibiotic resistance; Hadassah Hospital saves Al Quds student with organ failure, and much more.
An Israeli company developed technology that could speed up the process and improve bone quality in patients, and doctors at Hadassah Medical Center in Jerusalem removed a tumor from the spine of a 3-year-old Palestinian Arab boy from Gaza to prevent him from becoming paralyzed, and much more.
A day after she was born, Noa had a stroke and began convulsing. Now, two years later, a promising new treatment at the Sheba Medical Center at Tel Hashomer, outside of Tel Aviv, could help her battle cerebral palsy (CP).
Two Israeli companies have partnered to cut the risk of patient infections dramatically in 10 hospitals in the US, Switzerland and Israel, and doctors at Hadassah University Medical Centre in Jerusalem successfully treated 15 children from Russia who suffer from osteopetrosis, and much more.
Israel’s Eximo has successfully completed a clinical trial of its laser system and unique catheters for treating peripheral artery disease, and after 100% successful Mexican and European trials a prostate cancer drug has now been approved by Israel’s Ministry of Health.
Israeli students developed a one-handed thoracic portal opener that shortens the procedure time of chest-tube insertion from minutes to less than 30 seconds, and another Israeli researcher has discovered that Gallium in liquid form can rapidly halt uncontrolled bleeding, without causing blood clots.
Israel’s BioLight Life Sciences has completed a successful US clinical study designed to assess the effectiveness of a test evaluating tears’ components of patients suffering from dry eye syndrome, and Israeli startup SoniVie has a novel system for the treatment of pulmonary arterial hypertension.
Israeli researchers may have solved the main issue surrounding organ transplants, and researchers at Tel Aviv University have discovered evidence of colon cancer in the mummified remains of an 18th century Hungarian corpse.
Israeli startup Intensix is trialing an Intensive Care Unit patient monitoring system, which gives an early warning of impending sepsis and organ failure that kills 30% of ICU patients, and scientists at Israel’s Technion have discovered how to use proteins to suppress unwanted gene activity.
Tel Aviv University Professor Itzhak Fried has completed his study of how memory neurons behave in real time. These have important implications for understanding dementia such as Alzheimer’s, and an Israeli developed the world’s first search engine for information about hospitals.
A cancer study hailed this week as potentially showing revolutionary results for the treatment of leukemia is based on research undertaken by Prof. Zelig Eshhar of Israel’s Weizmann Institute of Science.